Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 130
Filtrar
1.
Med Oral Patol Oral Cir Bucal ; 29(5): e719-e726, 2024 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-39154252

RESUMEN

BACKGROUND: Oral cancer (OC) and oral potentially malignant disorders (OPMD) pose significant challenges to public health in Brazil. This study aimed to estimate the prevalence of oral cancer (OC) and oral potentially malignant disorders (OPMD) among patients who would be treated by Brazilian dentists during their careers. MATERIAL AND METHODS: Data on the number of dentists in Brazil were extracted from the 2022 census data, while incidence rates for OC cases were sourced from the Brazilian National Cancer Institute (INCA). Population estimates for Brazil and data on dental check-up rates were obtained from relevant national sources. RESULTS: Our analysis indicates that a general dentist in Brazil can expect to encounter on average two to three OC patients and on average 675 patients with OPMDs over a 35-year career. Regional disparities were observed, with certain regions showing higher than the average number of encounters due to low density of dentists in some rural districts. CONCLUSIONS: Brazilian dentists are likely to confront a substantial number of OC and OPMD cases during their professional tenure, emphasizing the need for public health policies aimed at enhancing dental surgeons' education in oral cancer prevention and early detection.


Asunto(s)
Neoplasias de la Boca , Humanos , Brasil/epidemiología , Neoplasias de la Boca/epidemiología , Prevalencia , Costo de Enfermedad , Lesiones Precancerosas/epidemiología
2.
Med Oral Patol Oral Cir Bucal ; 29(2): e280-e287, 2024 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-38150606

RESUMEN

BACKGROUND: There is no consensus about effective systemic therapy for salivary gland carcinomas (sgcs). Our aim was summarized the clinical trials assessing the systemic therapies (ST) on sgcs. MATERIAL AND METHODS: Electronic searches were carried out through MEDLINE/pubmed, EMBASE, Scopus, Web of Science, and the Cochrane Library databases, and gray literature. RESULTS: Seventeen different drugs were evaluated, and the most frequent histological subtype was adenoid cystic carcinoma (n=195, 45.5%). Stable disease, observed in 11 ST, achieved the highest rate in adenoid cystic carcinoma treated with sunitinib. The highest complete (11.1%) and partial response (30.5%) rates were seen in androgen receptor-positive tumors treated with leuprorelin acetate. CONCLUSIONS: Despite all the advances in this field, there is yet no effective evidence-based regimen of ST, with all the clinical trials identified showing low rates of complete and partial responses. Further, translational studies are urgently required to characterize molecular targets and effective ST.


Asunto(s)
Carcinoma Adenoide Quístico , Neoplasias de las Glándulas Salivales , Humanos , Carcinoma Adenoide Quístico/tratamiento farmacológico , Neoplasias de las Glándulas Salivales/tratamiento farmacológico , Bases de Datos Factuales , Glándulas Salivales
3.
Med Oral Patol Oral Cir Bucal ; 27(3): e274-e284, 2022 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-35368013

RESUMEN

BACKGROUND: Lip, oral cavity, and oropharyngeal squamous cell carcinoma (SCC) represent a major health problem in the global scenario. In South America, the highest incidence rates are seen in Brazil. Therefore, the epidemiological and clinical profile and survival outcomes of lip, oral cavity, and oropharyngeal SCC was studied in São Paulo State, Brazil. MATERIAL AND METHODS: The clinicopathological data of 12,099 patients with lip, oral cavity, and oropharyngeal SCC were obtained from hospital cancer registries of the Fundação Oncocentro de São Paulo, Brazil (2010-2015). Survival rates and other analyses were performed using SPSS software. RESULTS: A clear male predominance was observed, particularly for patients with oropharyngeal SCC (88.3%). The average age of patients was higher for lip cases (65 ± 13.5 years) compared to other sites. The schooling level was low for most patients, especially in lip cases (87.9%). Most of the patients with oral cavity (71.8%) and oropharyngeal (86.3%) SCC had advanced-stage (III-IV) disease. However, the majority of lip cases (83.3%) were at an early stage (I-II). Surgical excision was the main treatment for lip (72%) and oral cavity SCC (23.5%), and chemoradiotherapy was the main treatment for oropharyngeal SCC (40.2%). The 5-year overall survival (OS) for patients with lip, oral cavity, and oropharyngeal SCC were 66.3, 30.9, and 22.6%, respectively. Multivariate analysis revealed that the determinants of OS were different for lip, oral cavity, and oropharyngeal SCC, except for those at the clinical stage, which was an independent predictor for all sites. CONCLUSIONS: OS-independent determinants varied according to the affected site. Oral cavity and oropharyngeal SCC presented worse survival rates than those for lip SCC.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias de Cabeza y Cuello , Neoplasias de la Boca , Neoplasias Orofaríngeas , Anciano , Brasil/epidemiología , Carcinoma de Células Escamosas/epidemiología , Carcinoma de Células Escamosas/terapia , Femenino , Humanos , Labio/patología , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/epidemiología , Neoplasias de la Boca/terapia , Neoplasias Orofaríngeas/epidemiología , Neoplasias Orofaríngeas/terapia , Carcinoma de Células Escamosas de Cabeza y Cuello/epidemiología , Carcinoma de Células Escamosas de Cabeza y Cuello/terapia
4.
Med Oral Patol Oral Cir Bucal ; 26(1): e56-e63, 2021 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-32701932

RESUMEN

BACKGROUND: Tobacco, alcohol consumption, and HPV infection are the most common risk factors for head and neck cancer (HNC). Despite of this, recent evidences are growing on the association between long-term exposure to pesticides and the risk of chronic diseases, including different types of cancer. The present review evaluated in current literature evidence of an association between exposure to pesticides and the occurrence of HNCs. MATERIAL AND METHODS: A literature search of the case-control studies was conducted in the PubMed, Web of science and Cochrane databases. Methodological quality of each study was rated with the Scottish Intercollegiate Guidelines Network (SIGN 50) checklist. RESULTS: One thousand and thirty-five studies were identified and twelve met all criteria and, therefore, considered for quality assessment and data extraction. According to SIGN 50 criteria, six studies received an overall high-quality. All the studies considered of high quality found a positive association between exposure to pesticides and different HNC sites, including larynx, pharynx and nasal cavity. In addition, the increased risk was associated with the frequency of exposure. CONCLUSIONS: Finally, improving pesticide users' awareness of their risks and proper handling, as well as adopting protective measures such as the use of personal protective equipment, appear to be effective in reducing human health damage.


Asunto(s)
Neoplasias de Cabeza y Cuello , Infecciones por Papillomavirus , Plaguicidas , Consumo de Bebidas Alcohólicas , Estudios de Casos y Controles , Neoplasias de Cabeza y Cuello/inducido químicamente , Neoplasias de Cabeza y Cuello/epidemiología , Humanos , Plaguicidas/efectos adversos
5.
Med Oral Patol Oral Cir Bucal ; 25(1): e49-e55, 2020 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-31880289

RESUMEN

BACKGROUND: The objective of this study investigated the distribution of immature dendritic cells (DCs), Langerhans cells and plasmacytoid DCs in oral submucous fibrosis (OSMF), OSMF associated with oral squamous cell carcinoma (OSMF-OSCC), oral leukoplakia (OL), and oral squamous cell carcinoma (OSCC). MATERIAL AND METHODS: Fourteen cases of OSMF, 9 of OSMF-OSCC, 8 of OL¸ 45 of OSCC and 8 of normal epithelium were retrospectively retrieved and their diagnoses confirmed. Immunoreactions against CD1a, CD207 e CD303 were performed and the number of positive cells quantified. RESULTS: A significant decrease of CD1a+ was found in OSMF (p≤0.05), OSMF-OSCC (p ≤ 0.01), and OSCC (p ≤ 0.001) when compared to normal epithelium. For CD207+ the significance decrease was observed in OSMF-OSCC (p ≤ 0.05), and OSCC (p ≤ 0.01) when compared with normal epithelium, and in OSMF when compared with OL (p ≤ 0.05). There was no significant difference for CD303, but increased in CD303+ was observed in OSCC when compared with normal epithelium. CONCLUSION: The decrease in the number of CD1a+ and CD207+ cells may be associate to the development of oral OSCC, and in OPMDs they might be indicators of malignant transformation.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias de la Boca , Fibrosis de la Submucosa Bucal , Antígenos CD , Humanos , Lectinas Tipo C , Leucoplasia Bucal , Lectinas de Unión a Manosa , Estudios Retrospectivos
7.
Oral Oncol ; 83: 81-90, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-30098783

RESUMEN

OBJECTIVES: To identify potential molecular drivers associated with prognosis and response to treatment in advanced oropharyngeal squamous cell carcinomas (OPSCC). MATERIALS AND METHODS: Thirty-three OPSCC biopsies from untreated Brazilian patients were evaluated for human papilloma virus genotyping, genome wide copy number alterations and gene expression profiling. Data were integrated using CONEXIC algorithm. Validation with TCGA dataset and confirmation by RT-qPCR of candidate genes were performed. RESULTS: High-risk HPV positive cases, detected in 55% of advanced OPSCC, were associated with better outcome. Losses of 8p11.23-p11.22, 14q11.1-q11.2 and 15q11.2, and gains of 11q13.2 and 11q13.2-q13.3 were detected as recurrent alterations. Gains of 3q26.31 and 11q13.2 and losses of 9p21.3 were exclusively detected in HPV-negative tumors. Two clusters of expression profiles were observed, being one composed mostly by HPV positive cases (83%). HPV-positive enriched cluster showed predominantly immune response-related pathways. Integrative analysis identified 10 modulators mapped in 11q13, which were frequently cancer-related. These 10 genes showed copy number gains, overexpression and an association with worse survival, further validated by TCGA database analyses. Overexpression of four genes (ORAOV1, CPT1A, SHANK2 and PPFIA1) evaluated by RT-qPCR confirmed their association with poor survival. Multivariate analysis showed that PPFIA1 overexpression and HPV status are independent prognostic markers. Moreover, SHANK2 overexpression was significantly associated with incomplete response to treatment. CONCLUSION: The integrative genomic and transcriptomic data revealed potential driver genes mapped in 11q13 associated with worse prognosis and response to treatment, giving fundamentals for the identification of novel therapeutic targets in OPSCC.


Asunto(s)
Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/terapia , Cromosomas Humanos Par 11 , Oncogenes , Neoplasias Orofaríngeas/genética , Neoplasias Orofaríngeas/terapia , Resultado del Tratamiento , Proteínas Adaptadoras Transductoras de Señales/genética , Alphapapillomavirus/aislamiento & purificación , Carcinoma de Células Escamosas/virología , Mapeo Cromosómico , Femenino , Genómica , Humanos , Masculino , Persona de Mediana Edad , Proteínas del Tejido Nervioso/genética , Neoplasias Orofaríngeas/virología , Pronóstico , Transcriptoma
8.
Int J Oral Maxillofac Surg ; 47(7): 817-823, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29395668

RESUMEN

The aim of this study was to investigate epidermal growth factor receptor (EGFR) gene alterations in two groups of patients with oral squamous cell carcinoma (OSCC) (a test group of subjects aged ≤40 years and a control group of subjects aged ≥50 years) and to associate the results with EGFR immunostaining, clinicopathological features, and the prognosis. Sixty cases of OSCC were selected (test group, n=21; control group, n=39). The tissue microarray technique was applied to ensure the uniformity of results. Gene amplification was analyzed by fluorescence in situ hybridization (FISH), and immunohistochemical staining for EGFR was analyzed using an automated imaging system. EGFR amplification was higher in the test group than in the control group (P=0.018) and was associated with advanced clinical stage (P=0.013), regardless of age. Patients with EGFR overexpression had worse survival rates, as did patients who had T3-T4 tumours and positive margins. EGFR overexpression has a negative impact on disease progression. Despite the higher amplification of EGFR in young adults, it does not significantly impact the survival rates of affected patients.


Asunto(s)
Carcinoma de Células Escamosas/genética , Neoplasias de la Boca/genética , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/patología , Estudios de Casos y Controles , Niño , Progresión de la Enfermedad , Receptores ErbB/genética , Femenino , Amplificación de Genes , Humanos , Inmunohistoquímica , Hibridación Fluorescente in Situ , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/patología , Estadificación de Neoplasias , Pronóstico , Estudios Retrospectivos , Tasa de Supervivencia , Análisis de Matrices Tisulares
9.
Oral Dis ; 23(1): 120-125, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27667675

RESUMEN

OBJECTIVES: The aim of this study was to evaluate three histologic grading methods for squamous cell carcinoma (SCC) of the lip, the conventional three-grade model proposed by the World Health Organization, tumor budding and depth of invasion (BD) model, and histologic risk assessment (HRA) model, and to correlate them with prognosis. MATERIALS AND METHODS: Fifty-three patients with lip SCC were evaluated. RESULTS: The mean age was 65 years, 69.8% of the participants were men, and 66.0% of the patients had early-stage tumors. Using the BD and conventional three-grade methods, 52.8% and 64.2% of the cases were graded as low risk, respectively. The HRA model graded 54.7% of the cases as medium risk. In the BD model, the higher histologic grade was associated with worse prognosis (P = 0.045). Overall survival at 5 years was 87.8%. Tumor size (T3 + T4) and lymph node involvement (N+) were associated with reduced overall survival and recurrence-free survival (RFS) (P = 0.002 and 0.005; 0.007 and 0.01, respectively). Surgical treatment combined with radiotherapy was associated with lower RFS (P = 0.03). CONCLUSIONS: High-grade lip SCC in advanced stages is associated with a poor prognosis. The BD model is a simple and effective tool for the prognostic evaluation of lip SCC.


Asunto(s)
Carcinoma de Células Escamosas/patología , Neoplasias de los Labios/patología , Clasificación del Tumor/métodos , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/clasificación , Femenino , Humanos , Labio/patología , Neoplasias de los Labios/clasificación , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Estudios Retrospectivos
10.
Int J Oral Maxillofac Surg ; 45(2): 135-40, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26655030

RESUMEN

Head and neck mucosal melanoma (HNMM) is a rare and aggressive malignancy. The objective of this study was to describe the outcomes of patients with HNMM. Clinical and pathological data from 51 patients with primary HNMM were reviewed. All patients were treated at a single cancer centre between 1954 and 2012. Most tumours involved the nasal cavity (35.3%) and upper gingiva (29.4%). The majority of lesions were ulcerated (54.9%) and pigmented (84.3%). Forty-three patients underwent surgical treatment and 21 (41.2%) underwent adjuvant chemotherapy and/or radiotherapy. Eight patients (15.7%) received palliative treatment. The median follow-up period was 21 months. During this period, 30 (58.8%) patients had tumour recurrences. At the last clinical evaluation, only seven (13.7%) patients were alive with no evidence of disease and three (5.9%) were alive with HNMM. There were significant differences in overall survival probability according to the presence of ulceration (P=0.004), metastatic lymph nodes (P=0.003), and treatment including a radical surgical procedure (P<0.001). On multivariate analysis, ulceration was the only variable associated with an increased risk of death. Despite the poor prognosis, there was significant improvement in overall survival in the most recent years in this sample, mainly due to advances in diagnosis and reconstruction techniques.


Asunto(s)
Neoplasias de Cabeza y Cuello/patología , Neoplasias de Cabeza y Cuello/terapia , Melanoma/patología , Melanoma/terapia , Adulto , Anciano , Anciano de 80 o más Años , Brasil/epidemiología , Terapia Combinada , Femenino , Neoplasias de Cabeza y Cuello/mortalidad , Humanos , Metástasis Linfática , Masculino , Melanoma/mortalidad , Persona de Mediana Edad , Mucosa Bucal/patología , Mucosa Nasal/patología , Recurrencia Local de Neoplasia/mortalidad , Cuidados Paliativos , Pronóstico , Estudios Retrospectivos , Tasa de Supervivencia , Resultado del Tratamiento
11.
Int J Oral Maxillofac Surg ; 44(2): 143-50, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25457829

RESUMEN

The prognostication of patient outcome is one of the greatest challenges in the management of early stage oral tongue squamous cell carcinoma (OTSCC). This study introduces a simple histopathological model for the prognostication of survival in patients with early OTSCC. A total of 311 cases (from Finland and Brazil) with clinically evaluated early stage OTSCC (cT1-T2cN0cM0) were included in this multicentre retrospective study. Tumour budding (B) and depth of invasion (D) were scored on haematoxylin-eosin-stained cancer slides. The cut-off point for tumour budding was set at 5 buds (low <5; high ≥5) and for depth of invasion at 4mm (low <4mm; high ≥4mm). The scores of B and D were combined into one model: the BD predictive model. On multivariate analysis, a high risk score (BD score 2) correlated significantly with loco-regional recurrence (P=0.033) and death due to OTSCC (P<0.001) in early stage OTSCC. The new BD model is a promising prognostic tool to identify those patients with aggressive cases of early stage OTSCC who might benefit from multimodality treatment.


Asunto(s)
Carcinoma de Células Escamosas/patología , Neoplasias de la Lengua/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Brasil/epidemiología , Carcinoma de Células Escamosas/mortalidad , Niño , Femenino , Finlandia/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Estadificación de Neoplasias , Valor Predictivo de las Pruebas , Pronóstico , Estudios Retrospectivos , Medición de Riesgo , Análisis de Supervivencia , Neoplasias de la Lengua/mortalidad
12.
Int J Oral Maxillofac Surg ; 44(1): 23-8, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25457832

RESUMEN

Perineural invasion (PNI) and lymphovascular invasion (LVI) have been associated with the risk of local recurrences and lymph node metastasis. The aim of this study was to evaluate the prognostic impact of PNI and LVI in patients with advanced stage squamous cell carcinoma of the tongue and floor of the mouth. One hundred and forty-two patients without previous treatment were selected. These patients underwent radical surgery with neck dissection and adjuvant treatment. Clinicopathological data were retrieved from the medical charts, including histopathology and surgery reports. Univariate analysis was performed to assess the impact of studied variables on survival. Overall survival was negatively influenced by six tumour-related factors: increasing T stage (P = 0.003), more than two clinically positive nodes (P = 0.002), extracapsular spread of lymph node metastasis (P < 0.001), tumour thickness (P = 0.04), PNI (P < 0.001), and LVI (P = 0.012). Disease-free survival was influenced by PNI (P = 0.04), extracapsular spread of lymph node metastasis (P = 0.008), and N stage (P = 0.006). Multivariate analysis showed PNI to be an independent predictor for overall survival (P = 0.01) and disease-free survival (P = 0.03). Thus the presence of PNI in oral carcinoma surgical specimens has a significant impact on survival outcomes in patients with advanced stage tumours submitted to radical surgery and adjuvant radiotherapy/radiochemotherapy.


Asunto(s)
Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/cirugía , Neoplasias de la Boca/patología , Neoplasias de la Boca/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Quimioradioterapia , Terapia Combinada , Femenino , Humanos , Escisión del Ganglio Linfático , Metástasis Linfática , Masculino , Persona de Mediana Edad , Disección del Cuello , Invasividad Neoplásica , Estadificación de Neoplasias , Pronóstico , Estudios Retrospectivos , Factores de Riesgo , Tasa de Supervivencia
13.
Int J Oral Maxillofac Surg ; 43(7): 795-801, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24583139

RESUMEN

Although several histopathological parameters and grading systems have been described as predictive of the treatment response and outcome of oral squamous cell carcinoma (OSCC), none is universally accepted. A new scoring system, the histological risk model, was recently described to be a powerful predictive tool for recurrence and overall survival in OSCC. The aim of this study was to verify the predictive role of the histological risk model in a cohort of 202 patients at all stages of oral/mobile tongue squamous cell carcinoma (OTSCC). Demographic and clinical data were collected from the medical records and the tumours were evaluated using the histological risk model. Statistical analyses were performed using the χ(2) test, the Kaplan-Meier method, and the Cox regression model. The histological risk model showed no statistical correlation with demographic or clinical parameters and did not Predict the outcome of the OTSCC patients. However, multivariate regression analysis revealed a significant correlation of the clinical disease stage with the disease outcome. Despite major efforts to identify new predictive parameters and histological systems, clinical features are still the most reliable prognostic factors for patients with OTSCC.


Asunto(s)
Carcinoma de Células Escamosas/patología , Neoplasias de la Boca/patología , Neoplasias de la Lengua/patología , Adulto , Anciano , Anciano de 80 o más Años , Demografía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Invasividad Neoplásica , Recurrencia Local de Neoplasia , Valor Predictivo de las Pruebas , Pronóstico , Estudios Retrospectivos , Medición de Riesgo , Análisis de Supervivencia
14.
Arq. bras. med. vet. zootec ; 66(1): 268-276, fev. 2014. ilus, tab
Artículo en Portugués | VETINDEX | ID: vti-10289

RESUMEN

Objetivou-se avaliar as características de desempenho, consumo e eficiência alimentar de touros Purunã em crescimento de três classes de consumo alimentar residual (CAR): eficiente, intermediária e ineficiente. Foram avaliados 110 tourinhos com média de 10 meses de idade e 233kg de peso corporal (PC), distribuídos aleatoriamente em baias individuais em confinamento. A dieta, em base de matéria seca (MS), foi composta por 420g/kg de concentrado e 580g/kg de silagem de milho, e fornecida à vontade. O consumo de MS diário e o ganho médio diário (GMD) foram avaliados durante 112 dias. O PC inicial e final e o GMD foram semelhantes entre as classes de eficiência e apresentaram valores médios de 233kg, 360kg e 1,14kg/dia. Valores médios de 7,19; 7,62 e 8,10kg/dia para consumo de MS e -048; -0,01 e 0,48kg MS/dia para CAR foram observados nas classes eficiente, intermediária e ineficiente. A conversão alimentar (CA) e a eficiência alimentar bruta (EAB) foram semelhantes entre as classes eficiente e intermediária, e apresentaram média de 6,65kg MS/kg ganho e 153g ganho/kg MS. A classe ineficiente apresentou maior CA e menor EAB, com valores de 7,40kg MS/kg ganho e 138g ganho/kg MS. A eficiência parcial de crescimento (EPC) diferiu entre as classes de eficiência e apresentou valores médios de 294; 277 e 255g ganho/kg MS para crescimento nas classes eficiente, intermediária e ineficiente. O CAR apresentou correlação moderada a alta com CA, EAB e EPC, e a diminuição do CAR levou à redução da CA em 12,2%, e aumento da EAB e EPC em 13,3% e 15,5%. Tourinhos Purunã eficientes para CAR consomem menos alimento, mas mantêm o mesmo nível de produção que os ineficientes. Assim, a classificação com base no CAR permite a identificação de animais com potencial para melhorar a eficiência produtiva do rebanho.(AU)


This trial aimed to evaluate the performance, feed intake and feed efficiency traits of Purunã growing bulls of three groups of residual feed intake (RFI): efficient, intermediary and inefficient. There were used 110 growing bulls with average of 10 months of age and 233kg of body weight (BW) which were randomly allocated in individual feedlot pens. The diet was composed, in dry matter (DM) basis, by 420g/kg of concentrate and 580g/kg of corn silage, and was offered ad libitum. Daily dry matter intake (DMI) and average daily gain (ADG) were assessed during 112 days. Initial and final BW and ADG not differed between the efficiency groups and showed mean values of 233kg, 360kg and 1.14kg/d. Mean values of 7.19, 7.62 and 8.10kg/d to DMI and -0.48, -0.01 and 0.48kg DM/d to RFI were observed in efficient, intermediary and inefficient groups. Feed conversion ratio (FCR) and gross feed efficiency (GFE) not differed between efficient and intermediary groups, which showed means of 6.65kg DM/kg gain and 153g gain/kg DM. Inefficient group showed higher FCR and lower GFE, with mean values of 7.40kg DM/kg gain and 138g gain/kg DM. Partial efficiency of growth (PEG) differed between the efficiency groups and showed means of 294, 277 and 255g gain/kg DM for growth in efficient, intermediary and inefficient groups. RFI showed moderate to high correlations with FCR, GFE and PEG, and decrease of RFI resulted in decrease of FCR in 12.2%, increase of GFE in 13.3% and increase of PEG in 15.5%. Efficient Purunã growing bulls (low RFI) present lower feed intake, but maintains the same production level that inefficient ones (high RFI). Thus, RFI classification allows identifying animals with potential to improve the productive efficiency of herd.(AU)


Asunto(s)
Animales , Ensilaje , Zea mays , Dieta/veterinaria , Alimentación Animal , Bovinos/clasificación
15.
Arq. bras. med. vet. zootec ; Arq. bras. med. vet. zootec. (Online);66(1): 268-276, fev. 2014. ilus, tab
Artículo en Portugués | LILACS | ID: lil-704033

RESUMEN

Objetivou-se avaliar as características de desempenho, consumo e eficiência alimentar de touros Purunã em crescimento de três classes de consumo alimentar residual (CAR): eficiente, intermediária e ineficiente. Foram avaliados 110 tourinhos com média de 10 meses de idade e 233kg de peso corporal (PC), distribuídos aleatoriamente em baias individuais em confinamento. A dieta, em base de matéria seca (MS), foi composta por 420g/kg de concentrado e 580g/kg de silagem de milho, e fornecida à vontade. O consumo de MS diário e o ganho médio diário (GMD) foram avaliados durante 112 dias. O PC inicial e final e o GMD foram semelhantes entre as classes de eficiência e apresentaram valores médios de 233kg, 360kg e 1,14kg/dia. Valores médios de 7,19; 7,62 e 8,10kg/dia para consumo de MS e -048; -0,01 e 0,48kg MS/dia para CAR foram observados nas classes eficiente, intermediária e ineficiente. A conversão alimentar (CA) e a eficiência alimentar bruta (EAB) foram semelhantes entre as classes eficiente e intermediária, e apresentaram média de 6,65kg MS/kg ganho e 153g ganho/kg MS. A classe ineficiente apresentou maior CA e menor EAB, com valores de 7,40kg MS/kg ganho e 138g ganho/kg MS. A eficiência parcial de crescimento (EPC) diferiu entre as classes de eficiência e apresentou valores médios de 294; 277 e 255g ganho/kg MS para crescimento nas classes eficiente, intermediária e ineficiente. O CAR apresentou correlação moderada a alta com CA, EAB e EPC, e a diminuição do CAR levou à redução da CA em 12,2%, e aumento da EAB e EPC em 13,3% e 15,5%. Tourinhos Purunã eficientes para CAR consomem menos alimento, mas mantêm o mesmo nível de produção que os ineficientes. Assim, a classificação com base no CAR permite a identificação de animais com potencial para melhorar a eficiência produtiva do rebanho.


This trial aimed to evaluate the performance, feed intake and feed efficiency traits of Purunã growing bulls of three groups of residual feed intake (RFI): efficient, intermediary and inefficient. There were used 110 growing bulls with average of 10 months of age and 233kg of body weight (BW) which were randomly allocated in individual feedlot pens. The diet was composed, in dry matter (DM) basis, by 420g/kg of concentrate and 580g/kg of corn silage, and was offered ad libitum. Daily dry matter intake (DMI) and average daily gain (ADG) were assessed during 112 days. Initial and final BW and ADG not differed between the efficiency groups and showed mean values of 233kg, 360kg and 1.14kg/d. Mean values of 7.19, 7.62 and 8.10kg/d to DMI and -0.48, -0.01 and 0.48kg DM/d to RFI were observed in efficient, intermediary and inefficient groups. Feed conversion ratio (FCR) and gross feed efficiency (GFE) not differed between efficient and intermediary groups, which showed means of 6.65kg DM/kg gain and 153g gain/kg DM. Inefficient group showed higher FCR and lower GFE, with mean values of 7.40kg DM/kg gain and 138g gain/kg DM. Partial efficiency of growth (PEG) differed between the efficiency groups and showed means of 294, 277 and 255g gain/kg DM for growth in efficient, intermediary and inefficient groups. RFI showed moderate to high correlations with FCR, GFE and PEG, and decrease of RFI resulted in decrease of FCR in 12.2%, increase of GFE in 13.3% and increase of PEG in 15.5%. Efficient Purunã growing bulls (low RFI) present lower feed intake, but maintains the same production level that inefficient ones (high RFI). Thus, RFI classification allows identifying animals with potential to improve the productive efficiency of herd.


Asunto(s)
Animales , Alimentación Animal , Dieta/veterinaria , Ensilaje , Zea mays , Bovinos/clasificación
16.
Acta Otorhinolaryngol Ital ; 33(2): 137-40, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23853407

RESUMEN

Schwannomas are benign, encapsulated, slow-growing and usually solitary tumours originating from Schwann cells of the peripheral nerve sheath. Approximately 25-40% of cases are seen in the head and neck region, of which 1% in the oral cavity. We report a rare case of lingual schwannoma in a young woman who was treated with complete transoral excision, and also review the literature of the past two decades, analyzing epidemiological and clinical data of the 35 cases reported. Lingual schwannomas generally present as a painless lump with an average size of 2 cm in the fourth decade of life and with no gender predilection. Complete transoral excision can be considered standard treatment for these tumours, with no recurrences documented in the literature.


Asunto(s)
Neurilemoma , Neoplasias de la Lengua , Adulto , Femenino , Humanos , Neurilemoma/diagnóstico , Neurilemoma/cirugía , Neoplasias de la Lengua/diagnóstico , Neoplasias de la Lengua/cirugía
17.
Int J Oral Maxillofac Surg ; 42(6): 685-92, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23561262

RESUMEN

Carcinoma ex pleomorphic adenoma (CXPA) is a rare tumour, with different prevalence rates reported among studies. Epidemiological studies of large series of CXPAs in developing countries are scarce. The aim of the present study was to describe Brazilian patients with CXPA; this was a retrospective study of 38 patients. Demographic and clinico-pathological features were evaluated. No preferential gender was found, and the mean age at diagnosis was 57.6 years. The most commonly involved site was the parotid, followed by the submandibular and the minor salivary glands. A prevalence of clinical stages III and IV was observed at diagnosis. The most common histological subtypes were salivary duct carcinoma, adenocarcinoma not otherwise specified, myoepithelial carcinoma, and epithelial-myoepithelial carcinoma. Moreover, by invasive phase, most were frankly invasive carcinoma. Recurrence was observed in seven out of 24 patients with outcome information available, and all were invasive cases. All seven patients died of causes related to the disease. The distributions of cases according to age, gender, tumour location, and clinical stage were similar to those reported in the literature. Frankly invasive cases presented a worse prognosis. More information is needed to further our understanding of the clinico-pathological aspects of CXPA.


Asunto(s)
Adenoma Pleomórfico/patología , Carcinoma/patología , Neoplasias de las Glándulas Salivales/patología , Adenocarcinoma/patología , Adulto , Anciano , Anciano de 80 o más Años , Resultado Fatal , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mioepitelioma/patología , Invasividad Neoplásica/patología , Recurrencia Local de Neoplasia , Estadificación de Neoplasias , Estudios Retrospectivos
18.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;45(12): 1327-1333, Dec. 2012. ilus, tab
Artículo en Inglés | LILACS | ID: lil-659632

RESUMEN

CDKN2A encodes proteins such as p16 (INK4a), which negatively regulate the cell-cycle. Molecular genetic studies have revealed that deletions in CDKN2A occur frequently in cancer. Although p16 (INK4a) may be involved in tumor progression, the clinical impact and prognostic implications in head and neck squamous cell carcinoma (HNSCC) are controversial. The objective of this study was to evaluate the frequency of the immunohistochemical expression of p16 (INK4a) in 40 oropharynx and 35 larynx from HNSCC patients treated in a single institution and followed-up at least for 10 years in order to explore potential associations with clinicopathological outcomes and prognostic implications. Forty cases (53.3%) were positive for p16 (INK4a) and this expression was more intense in non-smoking patients (P = 0.050), whose tumors showed negative vascular embolization (P = 0.018), negative lymphatic permeation (P = 0.002), and clear surgical margins (P = 0.050). Importantly, on the basis of negative p16 (INK4a) expression, it was possible to predict a probability of lower survival (P = 0.055) as well as tumors presenting lymph node metastasis (P = 0.050) and capsular rupture (P = 0.0010). Furthermore, increased risk of recurrence was observed in tumors presenting capsular rupture (P = 0.0083). Taken together, the alteration in p16 (INK4a) appears to be a common event in patients with oropharynx and larynx squamous cell carcinoma and the negative expression of this protein correlated with poor prognosis.


Asunto(s)
Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Carcinoma de Células Escamosas/metabolismo , /metabolismo , Neoplasias Laríngeas/metabolismo , Neoplasias Orofaríngeas/metabolismo , Biomarcadores de Tumor/metabolismo , Progresión de la Enfermedad , Inmunohistoquímica , Pronóstico , Estudios Retrospectivos , Análisis de Supervivencia
19.
Braz J Med Biol Res ; 45(12): 1327-33, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22948376

RESUMEN

CDKN2A encodes proteins such as p16 (INK4a), which negatively regulate the cell-cycle. Molecular genetic studies have revealed that deletions in CDKN2A occur frequently in cancer. Although p16 (INK4a) may be involved in tumor progression, the clinical impact and prognostic implications in head and neck squamous cell carcinoma (HNSCC) are controversial. The objective of this study was to evaluate the frequency of the immunohistochemical expression of p16 (INK4a) in 40 oropharynx and 35 larynx from HNSCC patients treated in a single institution and followed-up at least for 10 years in order to explore potential associations with clinicopathological outcomes and prognostic implications. Forty cases (53.3%) were positive for p16 (INK4a) and this expression was more intense in non-smoking patients (P = 0.050), whose tumors showed negative vascular embolization (P = 0.018), negative lymphatic permeation (P = 0.002), and clear surgical margins (P = 0.050). Importantly, on the basis of negative p16 (INK4a) expression, it was possible to predict a probability of lower survival (P = 0.055) as well as tumors presenting lymph node metastasis (P = 0.050) and capsular rupture (P = 0.0010). Furthermore, increased risk of recurrence was observed in tumors presenting capsular rupture (P = 0.0083). Taken together, the alteration in p16 (INK4a) appears to be a common event in patients with oropharynx and larynx squamous cell carcinoma and the negative expression of this protein correlated with poor prognosis.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Carcinoma de Células Escamosas/metabolismo , Inhibidor p16 de la Quinasa Dependiente de Ciclina/metabolismo , Neoplasias Laríngeas/metabolismo , Neoplasias Orofaríngeas/metabolismo , Adulto , Anciano , Progresión de la Enfermedad , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Análisis de Supervivencia
20.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;45(2): 172-178, Feb. 2012. ilus, tab
Artículo en Inglés | LILACS | ID: lil-614569

RESUMEN

Loss of Y-chromosome has been correlated with older age in males. Furthermore, current evidence indicates that Y-chromosome loss also occurs in several human tumors, including head and neck carcinomas. However, the association between Y nullisomy and the occurrence of neoplasias in elderly men has not been well established. In the present study, the association between Y-chromosome loss and head and neck carcinomas was evaluated by comparison to cells from peripheral blood lymphocytes and normal mucosa of cancer-free individuals matched for age using dual-color fluorescence in situ hybridization. Twenty-one patients ranging in age from 28 to 68 years were divided into five-year groups for comparison with 16 cancer-free individuals matched for age. The medical records of all patients were examined to obtain clinical and histopathological data. None of the patients had undergone radiotherapy or chemotherapy before surgery. In all groups, the frequency of Y-chromosome loss was higher among patients than among normal reference subjects (P < 0.0001) and was not age-dependent. These data suggest that Y-chromosome loss is a tumor-specific alteration not associated with advanced age in head and neck carcinomas.


Asunto(s)
Adulto , Anciano , Humanos , Masculino , Persona de Mediana Edad , Deleción Cromosómica , Carcinoma de Células Escamosas/genética , Cromosomas Humanos Y/genética , Neoplasias de Cabeza y Cuello/genética , Edad de Inicio , Estudios de Casos y Controles , Hibridación Fluorescente in Situ , Cariotipo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA